Results 31 to 40 of about 535,314 (143)

Results of intravitreal dexamethasone implant (Ozurdex®) for retinal vascular diseases with macular edema: An observational study of real-life situations. [PDF]

open access: yesMedicine (Baltimore), 2022
To evaluate the efficacy of intravitreal dexamethasone implants (Ozurdex®) for the treatment of macular edema (ME) associated with retinal vascular diseases in real-life situations.
Jirarattanasopa P   +4 more
europepmc   +2 more sources

Impact of Different Clinical Baseline Characteristics on Intravitreal Dexamethasone Implant Ozurdex® Outcomes. [PDF]

open access: yesClin Ophthalmol, 2021
Purpose To determine the impact of different baseline clinical characteristics on the improvement in best corrected visual acuity (BCVA) in patients with diabetic macular edema (DME) who underwent the intravitreal dexamethasone implant (DEX) Ozurdex ...
Udaondo P   +3 more
europepmc   +2 more sources

Choroidal Detachment Secondary to Scleral Wound Leak After Ozurdex® Implantation in an Eye With Previous Vitrectomy: A Case Report. [PDF]

open access: yesCureus
Retinal vein occlusion (RVO) is a major cause of visual morbidity, and macular oedema secondary to RVO is increasingly managed with repeated dexamethasone intravitreal implant (Ozurdex®) therapy, particularly in eyes with suboptimal response to anti ...
Hussain S, Aziz KR, Shehata A.
europepmc   +2 more sources

A Case of Anterior Vitreous Displacement of the Intravitreal Dexamethasone Implant (Ozurdex®) in a Pseudophakic Eye. [PDF]

open access: yesCureus
Macular edema following branch retinal vein occlusion (BRVO) is a common cause of visual impairment. Treatment options include intravitreal anti-vascular endothelial growth factor injections as first-line therapy, followed by a dexamethasone implant ...
Mahdar A, Dubois P.
europepmc   +2 more sources

Topical Prednisolone Acetate Challenge as a Predictor of Intraocular Pressure Elevation Following Ozurdex® in Diabetic Macular Edema: A Retrospective Study. [PDF]

open access: yesCureus
Background Steroid-induced ocular hypertension remains a practical concern with intravitreal corticosteroid therapy. The dexamethasone implant (Ozurdex®) is widely used for diabetic macular edema (DME), yet increases in intraocular pressure (IOP) can ...
Alsatrawi AB, Alhaddar HB, Mubarak AR.
europepmc   +2 more sources

Use of a multifocal electroretinogram to evaluate the therapeutic effect of a single intravitreal dexamethasone implant, Ozurdex<sup>®</sup>, for refractory diabetic macular oedema. [PDF]

open access: yesInt J Retina Vitreous
To evaluate the therapeutic effect of a single intravitreal dexamethasone implant (Ozurdex®) in eyes with refractory diabetic macular oedema (DME) anatomically via optical coherence tomography (OCT) and functionally via best corrected visual acuity (BCVA)
Mohammed ARA   +3 more
europepmc   +2 more sources

Evaluation of the Effect of Intravitreal Dexamethasone (Ozurdex®) Implant on Intraocular Pressure in Vitrectomized and Non-Vitrectomized Eyes with Macular Edema. [PDF]

open access: yesTurk J Ophthalmol, 2021
Objectives: This study aimed to retrospectively evaluate the intraocular pressure (IOP) change in vitrectomized and non-vitrectomized patients receiving 0.7 mg intravitreal dexamethasone implant to treat macular edema due to different indications ...
Garlı M   +3 more
europepmc   +2 more sources

Ozurdex® Implant Inside the Capsular Bag: A Report of a Rare Case. [PDF]

open access: yesCureus
We report a rare case of an intravitreal dexamethasone implant (Ozurdex®) inadvertently located within the capsular bag following a uneventful cataract surgery. A 46-year-old female patient with a history of recalcitrant uveitis in the left eye presented
Verma L   +4 more
europepmc   +2 more sources

Efficacy of Intravitreal Dexamethasone Implant (Ozurdex<sup>®</sup>) in Naïve and Refractory Patients with Different Morphological Subtypes of Diabetic Macular Edema. [PDF]

open access: yesMedicina (Kaunas)
Background and Objectives: To investigate anatomical and functional outcomes in different morphological subtypes of diabetic macular edema (DME) treated with an intravitreal dexamethasone implant (Ozurdex) over 6 months follow-up.
Stavrakas P   +7 more
europepmc   +2 more sources

Dexamethasone intravitreal implant (Ozurdex®) for pediatric uveitis

open access: yesGraefe's Archive for Clinical and Experimental Ophthalmology, 2015
The purpose of this study was to investigate the safety and effectiveness of an intravitreally injected dexamethasone-containing implant (Ozurdex(A (R))) in the treatment of uveitis in ...
R. Sella   +5 more
semanticscholar   +2 more sources

Home - About - Disclaimer - Privacy